Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

rhEndostatin Protein Involving Pediatric Patients With Cancer

This study has been terminated.
(Lack of drug supply)
Sponsor:
Collaborator:
Children's Hospital Boston
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00165373
First received: September 9, 2005
Last updated: December 21, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)